ESR1 and breast cancer: The experimental design was in fact based on the assumption that the human breast cancer cell line estrogen-independent (MDA-MB-231) was void of any ER form and utilized to compare the effects of tocotrienols on the estrogen responsive breast cancer cell line, MCF7.